Mesenchymal stem cell therapy in cats: Current knowledge and future potential
- 26 February 2018
- journal article
- review article
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 20 (3) , 208-216
Abstract
Practical relevance: Stem cell therapy is an innovative field of scientific investigation with tremendous potential for clinical application in veterinary medicine. Based on the known desirable immunomodulatory properties of mesenchymal stem cells, this therapy holds promise for the treatment of a variety of inflammatory diseases in cats. Aims: This review details our current understanding of feline stem cell biology and proposed mechanism of action. Studies performed in feline clinical trials for diseases including gingivostomatitis, chronic enteropathy, asthma and kidney disease are summarized, with the goal of providing an overview of the current status of this treatment modality and its potential for the future.Keywords
This publication has 48 references indexed in Scilit:
- Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studiesStem Cell Research & Therapy, 2013
- Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem CellsCell Medicine, 2012
- Mesenchymal stem cell injection ameliorates chronic renal failure in a rat modelClinical Science, 2011
- Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: A pilot studyJournal of Feline Medicine and Surgery, 2011
- Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseasesAutoimmunity Reviews, 2011
- Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney modelRenal Failure, 2010
- Mesenchymal Stem Cells Attenuate Renal Fibrosis Through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney ModelStem Cells, 2009
- The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel diseaseVeterinary Microbiology, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004